One theme runs through many of the stories we featured in August: AI is moving beyond analyzing scientific data and deeper into the experimental process itself.
Claude coordinated protein-design models and operated laboratory equipment. PRAXIS ran enzyme experiments for a month. Lila Sciences and Vivodyne unveiled systems built to generate biological data at industrial scale.
But there was a lot more going on as well. GenBio launched the first concrete step towards its proposed AI-Driven Digital Organism, AI-written DNA switches worked in mouse embryos, and a personalized mRNA cancer treatment succeeded in Phase 3.
Here are ten biggest AI x bio stories of the month, in no particular order.